|
| New targets for resistant prostate cancer |
|
https://doi.org/10.18632/oncotarget.2544
Timothy C. Thompson, and Likun Li
|
| 8816-8817 |
|
| Axl as a mediator of cellular growth and survival |
|
https://doi.org/10.18632/oncotarget.2422
Haley Axelrod, and Kenneth J. Pienta
|
| 8818-8852 |
|
| Hypoxiainducible factors enhance glutamate signaling in cancer cells |
|
https://doi.org/10.18632/oncotarget.2593
Hongxia Hu, Naoharu Takano, Lisha Xiang, Daniele M. Gilkes, Weibo Luo, and Gregg L. Semenza
|
| 8853-8868 |
|
| In vivo quantification and perturbation of MycMax interactions and the impact on oncogenic potential |
|
https://doi.org/10.18632/oncotarget.2588
Philipp Raffeiner, Ruth Röck, Andrea Schraffl, Markus Hartl, Jonathan R. Hart, Kim D. Janda, Peter K. Vogt, Eduard Stefan, and Klaus Bister
|
| 8869-8878 |
|
| Small molecule restoration of wildtype structure and function of mutant p53 using a novel zincmetallochaperone based mechanism |
|
https://doi.org/10.18632/oncotarget.2432
Xin Yu, Adam R. Blanden, Sumana Narayanan, Lalithapriya Jayakumar, David Lubin, David Augeri, S. David Kimball, Stewart N. Loh, and Darren R. Carpizo
|
| 8879-8892 |
|
| MUC1C confers EMT and KRAS independence in mutant KRAS lung cancer cells |
|
https://doi.org/10.18632/oncotarget.2360
Akriti Kharbanda, Hasan Rajabi, Caining Jin, Maroof Alam, Kwok-Kin Wong, and Donald Kufe
|
| 8893-8905 |
|
| The head and neck cancer cell oncogenome: A platform for the development of precision molecular therapies |
|
https://doi.org/10.18632/oncotarget.2417
Daniel Martin, Martin C. Abba, Alfredo A. Molinolo, Lynn Vitale-Cross, Zhiyong Wang, Moraima Zaida, Naomi C. Delic, Yardena Samuels, Guy J. Lyons, and J. Silvio Gutkind
|
| 8906-8923 |
|
| Selected drugs that inhibit DNA methylation can preferentially kill p53 deficient cells |
|
https://doi.org/10.18632/oncotarget.2441
Lan Yi, Yvonne Sun, and Arnold Levine
|
| 8924-8936 |
|
| Outcomes of patients with advanced cancer and KRAS mutations in phase I clinical trials |
|
https://doi.org/10.18632/oncotarget.2339
Rabih Said, Yang Ye, Gerald Steven Falchook, Filip Janku, Aung Naing, Ralph Zinner, George R. Blumenschein Jr, Siqing Fu, David S. Hong, Sarina Anne Piha-Paul, Jennifer J. Wheler, Razelle Kurzrock, Gary A. Palmer, Kenneth Aldape, Kenneth . R Hess, and Apostolia Maria Tsimberidou
|
| 8937-8946 |
|
| Plerixafor as a chemosensitizing agent in pediatric acute lymphoblastic leukemia: efficacy and potential mechanisms of resistance to CXCR4 inhibition |
|
https://doi.org/10.18632/oncotarget.2407
Edward Allan R. Sison, Daniel Magoon, Li Li, Colleen E. Annesley, Donald Small, and Patrick Brown
|
| 8947-8958 |
|
| The functional characterization of long noncoding RNA SPRY4IT1 in human melanoma cells |
|
https://doi.org/10.18632/oncotarget.1863
Joseph Mazar, Wei Zhao, Ahmad M. Khalil, Bongyong Lee, John Shelley, Subramaniam S. Govindarajan, Fumiko Yamamoto, Maya Ratnam, Muhammad Nauman Aftab, Sheila Collins, Brian N. Finck, Xianlin Han, John S. Mattick, Marcel E. Dinger, and Ranjan J. Perera
|
| 8959-8969 |
|
| A novel tumor suppressor function of Kindlin3 in solid cancer |
|
https://doi.org/10.18632/oncotarget.2125
Ibtissem Djaafri, Farah Khayati, Suzanne Menashi, Jorg Tost, Marie-Pierre Podgorniak, Aurelie Sadoux, Antoine Daunay, Luis Teixeira, Jean Soulier, Ahmed Idbaih, Niclas Setterblad, Françoise Fauvel, Fabien Calvo, Anne Janin, Celeste Lebbé, and Samia Mourah
|
| 8970-8985 |
|
| Glycogen synthase kinase3β inhibition depletes the population of prostate cancer stem/progenitorlike cells and attenuates metastatic growth |
|
https://doi.org/10.18632/oncotarget.1510
Jan Kroon, Lars S. in 't Veld, Jeroen T. Buijs, Henry Cheung, Geertje van der Horst, and Gabri van der Pluijm
|
| 8986-8994 |
|
| The classspecific BCR tonic signal modulates lymphomagenesis in a cmyc deregulation transgenic model |
|
https://doi.org/10.18632/oncotarget.2297
Rada Amin, Abdelghafour Marfak, Céline Pangault, Christelle Oblet, Aurélie Chanut, Karin Tarte, Yves Denizot, and Michel Cogné
|
| 8995-9006 |
|
| A novel calciumdependent mechanism of acquired resistance to IGF1 receptor inhibition in prostate cancer cells |
|
https://doi.org/10.18632/oncotarget.2346
Cale D. Fahrenholtz, Ann M. Greene, Pedro J. Beltran, and Kerry L. Burnstein
|
| 9007-9021 |
|
| Novel robust biomarkers for human bladder cancer based on activation of intracellular signaling pathways |
|
https://doi.org/10.18632/oncotarget.2493
Ksenia Lezhnina, Olga Kovalchuk, Alexander A. Zhavoronkov, Mikhail B. Korzinkin, Anastasia A. Zabolotneva, Peter V. Shegay, Dmitry G. Sokov, Nurshat M. Gaifullin, Igor G. Rusakov, Alexander M. Aliper, Sergey A. Roumiantsev, Boris Y. Alekseev, Nikolay M. Borisov, and Anton A. Buzdin
|
| 9022-9032 |
|
| The BCL2 inhibitor ABT199 significantly enhances imatinibinduced cell death in chronic myeloid leukemia progenitors |
|
https://doi.org/10.18632/oncotarget.1925
Tun Kiat Ko, Charles T.H. Chuah, John W.J. Huang, King-Pan Ng, and S. Tiong Ong
|
| 9033-9038 |
|
| Chemosensitization of solid tumors by inhibition of BclxL expression using DNAzyme |
|
https://doi.org/10.18632/oncotarget.1996
Xiaohui Yu, Lifang Yang, Murray J. Cairns, Crispin Dass, Edward Saravolac, Xiong Li, and Lun-Quan Sun
|
| 9039-9048 |
|
| Targeting tyrosinekinases and estrogen receptor abrogates resistance to endocrine therapy in breast cancer |
|
https://doi.org/10.18632/oncotarget.2022
Shuying Liu, Xiaolong Meng, Huiqin Chen, Wenbin Liu, Todd Miller, Mandi Murph Yiling Lu, Fan Zhang, Mihai Gagea, Carlos L. Arteaga, Gordon B. Mills, Funda Meric-Bernstam, and Ana M. González-Angulo
|
| 9049-9064 |
|
| Gankyrin is a predictive and oncogenic factor in welldifferentiated and dedifferentiated liposarcoma |
|
https://doi.org/10.18632/oncotarget.2375
Ju-Ae Hwang, Heung-Mo Yang, Doo-Pyo Hong, Sung-Yeon Joo, Yoon-La Choi, Joo-Hung Park, Alexander J. Lazar, Raphael E. Pollock, Dina Lev, and Sung Joo Kim
|
| 9065-9078 |
|
| Prolactin induces upregulation of its cognate receptor in breast cancer cells via transcriptional activation of its generic promoter by crosstalk between ERα and STAT5 |
|
https://doi.org/10.18632/oncotarget.2376
Raghuveer Kavarthapu, Chon-Hwa Tsai Morris, and Maria L. Dufau
|
| 9079-9091 |
|
| LGR5 promotes the proliferation and tumor formation of cervical cancer cells through the Wnt/βcatenin signaling pathway |
|
https://doi.org/10.18632/oncotarget.2377
Qing Chen, Hao-Zhe Cao, and Peng-Sheng Zheng
|
| 9092-9105 |
|
| MicroRNA3395p inhibits colorectal tumorigenesis through regulation of the MDM2/p53 signaling |
|
https://doi.org/10.18632/oncotarget.2379
Cen Zhang, Juan Liu, Xiaolong Wang, Rui Wu, Meihua Lin, Saurabh V. Laddha, Qifeng Yang, Chang S. Chan, and Zhaohui Feng
|
| 9106-9117 |
|
| Antirheumatic agent auranofin induced apoptosis in chronic myeloid leukemia cells resistant to imatinib through both Bcr/Abldependent and independent mechanisms |
|
https://doi.org/10.18632/oncotarget.2361
Xin Chen, Xianping Shi, Chong Zhao, Xiaofen Li, Xiaoying Lan, Shouting Liu, Hongbiao Huang, Ningning Liu, Siyan Liao, Dan Zang, Wenbin Song, Quentin Liu, Bing Z. Carter, Ping Q. Dou, Xuejun Wang, and Jinbao Liu
|
| 9118-9132 |
|
| p70 S6 kinase drives ovarian cancer metastasis through multicellular spheroidperitoneum interaction and Pcadherin/β1 integrin signaling activation |
|
https://doi.org/10.18632/oncotarget.2362
Carman Ka Man Ip, Susan Yung, Tak-Mao Chan, Sai-Wah Tsao, and Alice Sze Tsai Wong
|
| 9133-9149 |
|
| Crizotinib exhibits antitumor activity by targeting ALK signaling not cMET in pancreatic cancer |
|
https://doi.org/10.18632/oncotarget.2363
Hong Hua Yan, Kyung Hee Jung, Mi Kwon Son, Zhenghuan Fang, Soo Jung Kim, Ye-Lim Ryu, Juyoung Kim, Mi-Hyun Kim, and Soon-Sun Hong
|
| 9150-9168 |
|
| Biphasic regulation of autophagy by miR96 in prostate cancer cells under hypoxia |
|
https://doi.org/10.18632/oncotarget.2396
Yi Ma, Hao-Zheng Yang, Bai-Jun Dong, Han-Bing Zou, Yan Zhou, Xian-Ming Kong, and Yi-Ran Huang
|
| 9169-9182 |
|
| Binding of a Smad4/Ets1 complex to a novel intragenic regulatory element in exon12 of FPGS underlies decreased gene expression and antifolate resistance in leukemia |
|
https://doi.org/10.18632/oncotarget.2399
Shachar Raz, Michal Stark, and Yehuda G. Assaraf
|
| 9183-9198 |
|
| Mutational analysis of genes coding for cell surface proteins in colorectal cancer cell lines reveal novel altered pathways druggable mutations and mutated epitopes for targeted therapy |
|
https://doi.org/10.18632/oncotarget.2374
Elisa Donnard, Paula F. Asprino, Bruna R. Correa, Fabiana Bettoni, Fernanda Koyama, Fabio C. Navarro, Rodrigo O. Perez, John Mariadason, Oliver M. Sieber, Robert L. Straussberg, Andrew J.G. Simpson, Denis L.F. Jardim, Luiz Fernando L. Reis, Raphael B. Parmigiani, Pedro A.F. Galante, and Anamaria A. Camargo
|
| 9199-9213 |
|
| Vav1 promotes lung cancer growth by instigating tumormicroenvironment crosstalk via growth factor secretion |
|
https://doi.org/10.18632/oncotarget.2400
Shulamit Sebban, Marganit Farago, Shiran Rabinovich, Galit Lazer, Yulia Idelchuck, Lena Ilan, Eli Pikarsky, and Shulamit Katzav
|
| 9214-9226 |
|
| Piperlongumine selectively kills cancer cells and increases cisplatin antitumor activity in head and neck cancer |
|
https://doi.org/10.18632/oncotarget.2402
Jong-Lyel Roh, Eun Hye Kim, Jin Young Park, Ji Won Kim, Minsu Kwon, and Byung-Heon Lee
|
| 9227-9238 |
|
| Efficacy of aerosol therapy of lung cancer correlates with EGFR paralysis induced by AvidinOXanchored biotinylated Cetuximab |
|
https://doi.org/10.18632/oncotarget.2409
Rita De Santis, Antonio Rosi, Anna Maria Anastasi, Caterina Chiapparino, Claudio Albertoni, Barbara Leoni, Angela Pelliccia, Daniela Santapaola, Valeria Carollo, Emanuele Marra, Luigi Aurisicchio, Brunilde Arseni, Maria Lucrezia Pacello, Gabriella Palmieri, Simone Battella, Fiorella Petronzelli, and Ferdinando Maria Milazzo
|
| 9239-9255 |
|
| Rpb3 promotes hepatocellular carcinoma through its Nterminus |
|
https://doi.org/10.18632/oncotarget.2389
Zhe-Ping Fang, Bei-Ge Jiang, Fa-Biao Zhang, Ai-Dong Wang, Yi-Ming Ji, Ji-Cheng Li, Wei-Ping Zhou, Hai-Xiong Han, and Wei-Jie Zhou
|
| 9256-9268 |
|
| DCLK1 facilitates intestinal tumor growth via enhancing pluripotency and epithelial mesenchymal transition |
|
https://doi.org/10.18632/oncotarget.2393
Parthasarathy Chandrakesan, Nathaniel Weygant, Randal May, Dongfeng Qu, Harisha R. Chinthalapally, Sripathi M. Sureban, Naushad Ali, Stan A. Lightfoot, Shahid Umar, and Courtney W. Houchen
|
| 9269-9280 |
|
| Loss of Trop2 causes ErbB3 activation through a neuregulin1dependent mechanism in the mesenchymal subtype of HNSCC |
|
https://doi.org/10.18632/oncotarget.2423
Kaihua Zhang, Lamont Jones, Sora Lim, Christopher A. Maher, Douglas Adkins, James Lewis, Randall J. Kimple, Elana J. Fertig, Christine H. Chung, Andreas Herrlich, Matthew J. Ellis, Brian A. Van Tine, and Loren S. Michel
|
| 9281-9294 |
|
| Combining targeted drugs to overcome and prevent resistance of solid cancers with some stemlike cell features |
|
https://doi.org/10.18632/oncotarget.2424
Elina Jokinen, Niina Laurila, Peppi Koivunen, and Jussi P. Koivunen
|
| 9295-9307 |
|
| Multidrug resistance protein 4/ ATP binding cassette transporter 4: a new potential therapeutic target for acute myeloid leukemia |
|
https://doi.org/10.18632/oncotarget.2425
Sabrina Copsel, Ariana Bruzzone, Maria May, Julien Beyrath, Victoria Wargon, Jeannette Cany, Frans G.M. Russel, Carina Shayo, and Carlos Davio
|
| 9308-9321 |
|
| P2Y2R activation by nucleotides released from the highly metastatic breast cancer cell contributes to premetastatic niche formation by mediating lysyl oxidase secretion collagen crosslinking and monocyte recruitment |
|
https://doi.org/10.18632/oncotarget.2427
Young Nak Joo, Hana Jin, So Young Eun, Sang Won Park, Ki Churl Chang, and Hye Jung Kim
|
| 9322-9334 |
|
| Androgen deprivation therapy sensitizes prostate cancer cells to Tcell killing through androgen receptor dependent modulation of the apoptotic pathway |
|
https://doi.org/10.18632/oncotarget.2429
Andressa Ardiani, Sofia R. Gameiro, Anna R. Kwilas, Renee N. Donahue, and James W. Hodge
|
| 9335-9348 |
|
| Transcriptional coactivator CBP upregulates hTERT expression and tumor growth and predicts poor prognosis in human lung cancers |
|
https://doi.org/10.18632/oncotarget.2430
Wei Guo, Jianjun Lu, Meng Dai, Taihua Wu, Zhenlong Yu, Jingshu Wang, Wangbing Chen, Dingbo Shi, Wendan Yu, Yao Xiao, Canhui Yi, Zhipeng Tang, Tingting Xu, Xiangsheng Xiao, Yuhui Yuan, Quentin Liu, Guangwei Du, and Wuguo Deng
|
| 9349-9361 |
|
| The fatty acid synthase inhibitor triclosan: repurposing an antimicrobial agent for targeting prostate cancer |
|
https://doi.org/10.18632/oncotarget.2433
Martin C. Sadowski, Rebecca H. Pouwer, Jennifer H. Gunter, Amy A. Lubik, Ronald J. Quinn, and Colleen C. Nelson
|
| 9362-9381 |
|
| Transcriptional profiling of GBM invasion genes identifies effective inhibitors of the LIM kinaseCofilin pathway |
|
https://doi.org/10.18632/oncotarget.2412
Jun-Bum Park, Sameer Agnihotri, Brian Golbourn, Kelsey C. Bertrand, Amanda Luck, Nesrin Sabha, Christian A. Smith, Sara Byron, Gelareh Zadeh, Sidney Croul, Michael Berens, and James T. Rutka
|
| 9382-9395 |
|
| The DNA2 nuclease/helicase is an estrogendependent gene mutated in breast and ovarian cancers |
|
https://doi.org/10.18632/oncotarget.2414
Carmit Strauss, Maya Kornowski, Avraham Benvenisty, Amit Shahar, Hadas Masury, Ittai Ben-Porath, Tommer Ravid, Ayelet Arbel-Eden, and Michal Goldberg
|
| 9396-9409 |
|
| Overexpression of Collagen Triple Helix Repeat Containing 1 CTHRC1 is associated with tumour aggressiveness and poor prognosis in human nonsmall cell lung cancer |
|
https://doi.org/10.18632/oncotarget.2421
Zunfu Ke, Weiling He, Yuanhui Lai, Xuefeng Guo, Sharon Chen, Shuhua Li, Yuefeng Wang, and Liantang Wang
|
| 9410-9424 |
|
| Epigenetic signatures of alcohol abuse and hepatitis infection during human hepatocarcinogenesis |
|
https://doi.org/10.18632/oncotarget.2444
Ryan A. Hlady, Rochelle L. Tiedemann, William Puszyk, Ivan Zendejas, Lewis R. Roberts, Jeong-Hyeon Choi, Chen Liu, and Keith D. Robertson
|
| 9425-9443 |
|
| miR5245p suppresses the growth of oncogenic BRAF melanoma by targeting BRAF and ERK2 |
|
https://doi.org/10.18632/oncotarget.2452
Szu-Mam Liu, Jean Lu, Hoong-Chien Lee, Feng-Hsiang Chung, and Nianhan Ma
|
| 9444-9459 |
|
| GUCY2C lysosomotropic endocytosis delivers immunotoxin therapy to metastatic colorectal cancer |
|
https://doi.org/10.18632/oncotarget.2455
Glen P. Marszalowicz, Adam E. Snook, Michael S. Magee, Dante Merlino, Lisa D. Berman-Booty, and Scott A. Waldman
|
| 9460-9471 |
|
| miR382 inhibits tumor growth and enhance chemosensitivity in osteosarcoma |
|
https://doi.org/10.18632/oncotarget.2418
Meng Xu, Hua Jin, Cheng-Xiong Xu, Bo Sun, Zhi Mao, Wen-Zhi Bi, and Yan Wang
|
| 9472-9483 |
|
| What makes a blood cell based miRNA expression pattern disease specific A miRNome analysis of blood cell subsets in lung cancer patients and healthy controls |
|
https://doi.org/10.18632/oncotarget.2419
Petra Leidinger, Christina Backes, Indra N. Dahmke, Valentina Galata, Hanno Huwer, Ingo Stehle, Robert Bals, Andreas Keller, and Eckart Meese
|
| 9484-9497 |
|
| TOP2Ahigh is the phenotype of recurrence and metastasis whereas TOP2Aneg cells represent cancer stem cells in prostate cancer |
|
https://doi.org/10.18632/oncotarget.2411
Xuefeng Li, Yunying Liu, Wenqi Chen, Yuxiang Fang, Huiming Xu, HelenHe Zhu, Mingliang Chu, Wang Li, Guanglei Zhuang, and Wei-Qiang Gao
|
| 9498-9513 |
|
| FOXF1 mediates mesenchymal stem cell fusioninduced reprogramming of lung cancer cells |
|
https://doi.org/10.18632/oncotarget.2413
Hong-Jian Wei, Wen-Cheng Lo, Jac A. Nickoloff, Wei-Hong Chen, Hen-Yu Liu, Ya-Ting Chang, Pan-Chyr Yang, Cheng-Wen Wu, David F. Williams, Juri G. Gelovani, and Win-Ping Deng
|
| 9514-9529 |
